Veracyte (VCYT) Debt to Equity (2012 - 2026)

Veracyte (VCYT) posted Debt to Equity of $0.0 for Q1 2026, down 28.19% sequentially from $0.0 in Q4 2025, and down 93.92% YoY from $0.01 in Q1 2025.

Veracyte (VCYT) Debt to Equity (2012 - 2026) Analysis & Trends

Veracyte (VCYT) has 15 years of Debt to Equity data on file, last reported at $0.0 in Q1 2026.

Quarterly Debt to Equity fell 93.92% year-over-year to $0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.0 (down 93.92% YoY) and the FY2025 annual result came in at $0.0, down 92.96% from the prior year.
Debt to Equity declined to $0.0 in Q1 2026 per VCYT's latest filing, from $0.0 in the prior quarter.
The five-year high for Debt to Equity was $0.01 in Q4 2024, with the low at $0.0 in Q1 2026.
Average Debt to Equity over 5 years is $0.01, with a median of $0.01 recorded in 2022.
Year-over-year, Debt to Equity jumped 467.44% in 2024 and tumbled 93.92% in 2026.
Veracyte's Debt to Equity stood at $0.01 in 2022, then sank by 54.85% to $0.0 in 2023, then jumped by 467.44% to $0.01 in 2024, then plunged by 92.96% to $0.0 in 2025, then declined by 28.19% to $0.0 in 2026.
Business Quant data shows VCYT's Debt to Equity at $0.0 in Q1 2026, $0.0 in Q4 2025, and $0.01 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt/Equity (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	0.32
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	0.83
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	0.35
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	0.53
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	0.01
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	-1.50
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	2.49
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	0.56
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	-53.21
10	Veracyte	4.76 Bn	4.50 Bn	101.16 Mn	0.00

Download Data